Afuco™ Anti-Human KRT8 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-KRT8 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies specific to human CK8 are used for preventing and treating colorectal cancers.
Supplier Creative Biolabs
Product # AFC-456CL
Pricing Inquiry
Host Humanized
Target KRT8
Species Reactivity Human
Type ADCC enhanced antibody
Storage 4 °C, -20°C if preferred
Feedback